Interestingly, when comparing the expression of ENTR1/PTPN13 with Fas a significant proportion of colon cancer samples exhibit upregulated ENTR1 or PTPN13 and concomitantly downregulation of Fas expression levels. This evidence concerns the gene ENTR1 and malignant colon neoplasm.